Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,425.00    0.00 (0.00%)
Bid:
5,400.00
Ask:
5,600.00
Spread: 200.00 (3.704%)
Market Cap: £137.13m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Governance changes

2 Nov 2020 07:15

RNS Number : 8520D
Camellia PLC
02 November 2020
 

2 November 2020

 

Camellia Plc

Governance changes

Following allegations of serious human rights abuses at Kakuzi Plc in Kenya, Camellia has been reviewing its governance and safeguarding oversight arrangements and is setting up a Safeguarding and Stewardship Committee of Camellia's Board of Directors.

Camellia is also pushing the Boards of the companies we invest in to look at their own procedures, and where necessary make operational changes.

Camellia welcomes the news that Kakuzi has taken further steps to upgrade its governance and safeguarding measures. Details are set out in Kakuzi's announcement which is reproduced below. They include establishing an Independent Human Rights Advisory Committee and setting up an Operational-level Grievance Mechanism in line with UN Guiding Principles on Business and Human Rights.

These are important steps forward so that local communities, Kakuzi, and all those who depend upon it for their livelihoods can thrive together in the years to come.

Camellia will continue to do all it can to ensure that companies it invests in operate to the highest standards of governance.

 

Enquiries

Camellia Plc 01622 746655

Tom Franks, CEO

Susan Walker, CFO

 

Panmure Gordon 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Erik Anderson

 

Maitland/AMO

PR

William Clutterbuck 07785 292617

 

 

KAKUZI PLC

Board changes, establishment of Independent Human Rights Advisory Committee to the Board and of an Operational-level Grievance Mechanism

 

Board changes

The Board of Kakuzi Plc is pleased to announce that Nicholas Nganga has been appointed Chairman of the Board with immediate effect. He takes over from Graham Mclean who steps down from the role but will remain a non-executive Director. Among his other roles, Nicholas Nganga was Chairman of Safaricom, Kenya's leading telecoms operator, from 2007 until 2020, and is current Chairman of Car & General Kenya Limited and G4S Security.

Dr John Kibunga Kimani has been appointed to the Board of Kakuzi Plc as a non-executive Director with effect from 1 November 2020. Dr John Kimani has extensive experience in the agricultural sector (public and private) including planning, development and administration of small-holder agricultural extension programmes at District level, developing and managing small-holder irrigation projects and preparing long-range plans for land and water resources across Kenya. Notably he led the planning team in the Tana and Athi River basins embracing six districts of what were Central, Eastern and Coast Provinces of Kenya. He has worked with Government agricultural projects aided by the World Bank, SNV of the Netherlands, JICA of Japan, DANIDA of Denmark and GTZ of Germany.

In addition to being a fellow of the Economic Development Institute of the World Bank, Dr John Kimani has a Bsc in Agriculture (Makerere University College, Uganda); an Msc in Agricultural Economics (Reading University, U.K) and a Phd in Development Studies, Economics and Socio-anthropology (University of Sussex, U.K). Dr John Kimani is a member of the Agricultural Society of Kenya as well as a member of the Avocado Exporters Association of Kenya.

 

In addition to the above, the Board agreed on the following:

Independent Human Rights Advisory Committee

To enhance governance structures within Kakuzi Plc, the Board is establishing an Independent Human Rights Advisory Committee (IHRAC). The IHRAC will comprise experienced and distinguished individuals drawn from the human rights sector locally and internationally, and representatives of our stakeholders. Andrew Ndegwa Njoroge, a non-executive independent director of Kakuzi plc, will sit on the IHRAC.

 

Operational-level Grievance Mechanism

The Board is also upgrading Kakuzi's current alternative dispute resolution process by setting up a full Operational-level Grievance Mechanism (OGM), as defined by the UN Guiding Principles on Business and Human Rights. This will enable members of the community to have their grievances heard and resolved quickly, impartially and in accordance with internationally recognized best practices. It will also ensure that appropriate action is taken to deal with anyone who fails to live up to the standards Kakuzi Plc expects of its employees.

 

Nick Nganga, Chairman of Kakuzi Plc, said:

"Kakuzi sells its produce both locally and across the world. We must always ensure our corporate policies and human rights processes evolve to accommodate feedback and input from our employees, communities and other stakeholders, wherever they are based.  The changes and initiatives announced by the Board today are important steps in this regard. Dr Kimani will be a valuable addition to the Kakuzi Board. He knows Kakuzi well having grown up on the farm. He has an impressive and well-respected track record in the agricultural sector of this country which he built up working in private and public sector enterprises and projects.  "The Independent Human Rights Advisory Committee and the Operational-level Grievance Mechanism are significant enhancements to Kakuzi's governance processes. They underscore our determination to take a 'belt and braces' approach to human rights."  

31st October 2020

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBBBMTMTBMTIM
Date   Source Headline
4th Jun 202612:31 pmRNSResult of AGM
22nd May 20267:00 amRNSSale of Chalouni Tea Estate
5th May 20267:00 amRNSFinal Results
7th Apr 20264:19 pmRNSProposed Sale of Chalouni Tea Estate
1st Apr 20267:00 amRNSArtwork Sale and Update on Indian Tea Estate MOU
23rd Feb 20267:00 amRNSTrading Update
23rd Jan 20267:00 amRNSDirectorate change
27th Nov 20257:00 amRNSKakuzi Land Claims
8th Sep 20254:47 pmRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSHalf Year Results
26th Aug 20257:00 amRNSNotice of Half Year Results
4th Jul 20254:30 pmRNSDisposal
13th Jun 20254:01 pmRNSHolding(s) in Company
13th Jun 20252:35 pmRNSHolding(s) in Company
10th Jun 20259:09 amRNSHolding(s) in Company
9th Jun 20254:39 pmRNSHolding(s) in Company 9 June 2025
6th Jun 20257:00 amRNSResult of Tender Offer
5th Jun 20252:02 pmRNSResult of General Meetings
19th May 20257:00 amRNSValue Enhancement Plan
19th May 20257:00 amRNSTender Offer
13th May 20257:00 amRNSHolding(s) in Company
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSValue Enhancement Plan Date & Presentation
30th Apr 20257:00 amRNSFinal Results
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSPotential Disposal
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20259:07 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSDisposal
11th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20257:00 amRNSPotential Disposal
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.